Cargando…
The Lab4P Consortium of Probiotics Attenuates Atherosclerosis in LDL Receptor Deficient Mice Fed a High Fat Diet and Causes Plaque Stabilization by Inhibiting Inflammation and Several Pro‐Atherogenic Processes
SCOPE: Previous studies show that Lab4 probiotic consortium plus Lactobacillus plantarum CUL66 (Lab4P) reduces diet‐induced weight gain and plasma cholesterol levels in C57BL/6J mice fed a high fat diet (HFD). The effect of Lab4P on atherosclerosis is not known and is therefore investigated. METHODS...
Autores principales: | O'Morain, Victoria L., Chan, Yee‐Hung, Williams, Jessica O., Alotibi, Reem, Alahmadi, Alaa, Rodrigues, Neil P., Plummer, Sue F., Hughes, Timothy R., Michael, Daryn R., Ramji, Dipak P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373067/ https://www.ncbi.nlm.nih.gov/pubmed/34216185 http://dx.doi.org/10.1002/mnfr.202100214 |
Ejemplares similares
-
Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
por: O’Morain, Victoria L., et al.
Publicado: (2023) -
Pro‐atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation
por: Al‐Ahmadi, Wijdan, et al.
Publicado: (2021) -
Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat diet
por: Moss, Joe W. E., et al.
Publicado: (2021) -
Electronegative LDL from Rabbits Fed with Atherogenic Diet Is Highly Proinflammatory
por: Chang, Po-Yuan, et al.
Publicado: (2019) -
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
por: Michael, D. R., et al.
Publicado: (2021)